biomarkers – Page 2

Hereditary Disease Foundation (HDF) conference 2022 – Day 1

9 min read

Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2022 HDF Milton Wexler Biennial Symposium #HDF2022

By Dr Rachel Harding & Dr Sarah Hernandez

August 30, 2022

Updates from uniQure about their gene therapy for Huntington's disease

10 min read

uniQure is conducting safety trials of the first gene therapy for HD. A recent press release provided a 1 year update on the first group of 10 people who underwent surgery to receive this experimental drug. Let’s talk more about what it means.

By Dr Leora Fox & Dr Rachel Harding

July 5, 2022

Does blood hold the key to testing treatments earlier in HD patients?

5 min read

A new study by researchers at Johns Hopkins describes a non-invasive way to track progression of Huntington’s disease. This could be used before patients even start showing symptoms to help test treatments in early stages of disease.

By Dr Rachel Harding

August 4, 2021

HD Young Adult Study defines the sweet spot: symptom-free with measurable changes

7 min read

We know that HD-related changes can occur many years before symptom onset, but how early do those changes begin? A team of researchers set out to determine that with a new comprehensive study in pre-manifest HD young adults.

By Dr Sarah Hernandez

May 27, 2020